In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
The clinical hold follows Intellia's disclosure that it paused dosing in two Phase III trials after a patient experienced a serious adverse event.
A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...
A research team has successfully engineered a japonica rice variety using CRISPR/Cas9 to simultaneously optimize plant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback